International consultation on urologic diseases and the European association of urology international consultation on locally advanced renal cell carcinoma

European Urology

Volumn 60, Issue 4, 2011, Pages 673-683

  Margulis, Vitaly ^a   Master, Viraj A ^b   Cost, Nicholas G ^a   Leibovich, Bradley C ^c   Joniau, Steven ^d   Kuczyk, Markus ^e   Mulders, Peter F ^f   Kirkali, Ziya ^g   Wirth, Manfred P ^h   Hirao, Yoshihiko ⁱ   Rawal, Sudhir ^j   Chong, Tsung Wen ^k   Wood, Christopher G ^l  

^a UT Southwestern Medical Centre   (United States)

^b EMORY UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e UNIVERSITY OF TÜBINGEN   (Germany)

^f DOKUZ EYLUL UNIVERSITY   (Turkey)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

ⁱ NARA MEDICAL UNIVERSITY   (Japan)

^j RAJIV GANDHI CANCER INSTITUTE AND RESEARCH CENTRE   (India)

^k SINGAPORE GENERAL HOSPITAL   (Singapore)

^l UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

more..

Author keywords

Consensus statements; Local advanced renal cell carcinoma; Renal cell carcinoma

Indexed keywords

ALKALINE PHOSPHATASE; LACTATE DEHYDROGENASE; TUMOR MARKER;

ADVANCED CANCER; ALKALINE PHOSPHATASE BLOOD LEVEL; CANCER INVASION; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURGERY; CANCER THERAPY; DISEASE MARKER; HUMAN; KIDNEY CARCINOMA; KIDNEY METASTASIS; LACTATE DEHYDROGENASE BLOOD LEVEL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL SOCIETY; MOLECULAR THERAPY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THROMBOSIS;

CARCINOMA, RENAL CELL; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; KIDNEY NEOPLASMS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEPHRECTOMY; PATIENT SELECTION; PROGNOSIS; TREATMENT OUTCOME;

EID: 80052272210     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2011.06.042     Document Type: Review

References (86)

1. B.C. Leibovich, and M.L. Blute Surgical management of renal cell carcinoma Semin Oncol 33 2006 552 562 (Pubitemid 44511977)
2. K.M. Jacobsohn, and C.G. Wood Adjuvant therapy for renal cell carcinoma Semin Oncol 33 2006 576 582 (Pubitemid 44511976)
3. N.B. Haas, and R. Uzzo Adjuvant therapy for renal cell carcinoma Curr Oncol Rep 10 2008 245 252
4. V.F. Marshall, R.G. Middleton, G.R. Holswade, and E.I. Goldsmith Surgery for renal cell carcinoma in the vena cava J Urol 103 1970 414 420
5. M.L. Blute, B.C. Leibovich, C.M. Lohse, J.C. Cheville, and H. Zincke The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus BJU Int 94 2004 33 41 (Pubitemid 38980305)
6. S.A. Boorjian, S. Sengupta, and M.L. Blute Renal cell carcinoma: vena caval involvement BJU Int 99 2007 1239 1244 (Pubitemid 46624170)
7. A. Oto, B.R. Herts, E.M. Remer, and A.C. Novick Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment AJR Am J Roentgenol 171 1998 1619 1624 (Pubitemid 28531634)
8. T.J. Guzzo, P.M. Pierorazio, E.M. Schaeffer, E.K. Fishman, and M.E. Allaf The accuracy of multidetector computerized tomography for evaluating tumor thrombus in patients with renal cell carcinoma J Urol 181 2009 486 490 discussion 491
9. P.I. Karakiewicz, N. Suardi, and C. Jeldres Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi Eur Urol 53 2008 845 848 (Pubitemid 351273883)
10. F. Di Silverio, A. Sciarra, and U. Parente Neoadjuvant therapy with sorafenib in advanced renal cell carcinoma with vena cava extension submitted to radical nephrectomy Urol Int 80 2008 451 453 (Pubitemid 351915038)
11. B. Shuch, S.B. Riggs, and J.C. LaRochelle Neoadjuvant targeted therapy and advanced kidney cancer: observations and implications for a new treatment paradigm BJU Int 102 2008 692 696
12. N.G. Cost, S.E. Delacroix Jr., and J.P. Sleeper The impact of targeted molecular therapies on the level of renal cell carcinoma vena caval tumor thrombus Eur Urol 59 2011 912 918
13. A. Haferkamp, P.J. Bastian, and H. Jakobi Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup J Urol 177 2007 1703 1708 (Pubitemid 46560667)
14. V.S. Subramanian, A.J. Stephenson, D.A. Goldfarb, A.F. Fergany, A.C. Novick, and V. Krishnamurthi Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi Urology 74 2009 154 159
15. A. Henderson, D. Murphy, K. Jaganathan, W.W. Roberts, J.S. Wolf Jr., and A. Rane Hand-assisted laparoscopic nephrectomy for renal cell cancer with renal vein tumor thrombus Urology 72 2008 268 272
16. G.L. Martin, E.P. Castle, and A.D. Martin Outcomes of laparoscopic radical nephrectomy in the setting of vena caval and renal vein thrombus: seven-year experience J Endourol 22 2008 1681 1685
17. C.G. Rogers, W.M. Linehan, and P.A. Pinto Robotic nephrectomy for kidney cancer in a horseshoe kidney with renal vein tumor thrombus: novel technique for thrombectomy J Endourol 22 2008 1561 1563 discussion 1563
18. R. Bertini, M. Roscigno, and E. Lapenna Radical nephrocapsulectomy and caval thrombectomy with extracorporeal circulation and deep hypothermic circulatory arrest in right anterior minithoracotomy: a minimally invasive approach Urology 71 2008 957 961
19. A. Mazzola, R. Gregorini, and C. Villani Cavoatrial tumor thrombectomy with systemic circulatory arrest and antegrade cerebral perfusion Ann Thorac Surg 83 2007 1564 1565 (Pubitemid 46440723)
20. U.K. Chowdhury, A.K. Mishra, and A. Seth Novel techniques for tumor thrombectomy for renal cell carcinoma with intraatrial tumor thrombus Ann Thorac Surg 83 2007 1731 1736 (Pubitemid 46616790)
21. C.F. Granberg, S.A. Boorjian, and H.V. Schaff Surgical management, complications, and outcome of radical nephrectomy with inferior vena cava tumor thrombectomy facilitated by vascular bypass Urology 72 2008 148 152
22. M.L. Blute, S.A. Boorjian, B.C. Leibovich, C.M. Lohse, I. Frank, and R.J. Karnes Results of inferior vena caval interruption by greenfield filter, ligation or resection during radical nephrectomy and tumor thrombectomy J Urol 178 2007 440 445 discussion 444 (Pubitemid 47030500)
23. P.A. Hatcher, E.E. Anderson, D.F. Paulson, C.C. Carson, and J.E. Robertson Surgical management and prognosis of renal cell carcinoma invading the vena cava J Urol 145 1991 20 23 discussion 23-4
24. H.L. Kim, A. Zisman, K.R. Han, R.A. Figlin, and A.S. Belldegrun Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol 171 2004 588 591 (Pubitemid 38090435)
25. B.C. Leibovich, J.C. Cheville, and C.M. Lohse Cancer specific survival for patients with pT3 renal cell carcinoma - can the 2002 primary tumor classification be improved? J Urol 173 2005 716 719 (Pubitemid 40239326)
26. F.F. Marshall, D.D. Dietrick, W.A. Baumgartner, and B.A. Reitz Surgical management of renal cell carcinoma with intracaval neoplastic extension above the hepatic veins J Urol 139 1988 1166 1172
27. J.E. Montie, J.E. Pontes, and A.C. Novick Resection of inferior vena cava tumor thrombi from renal cell carcinoma Am Surg 57 1991 56 61
28. R.J. Neves, and H. Zincke Surgical treatment of renal cancer with vena cava extension Br J Urol 59 1987 390 395 (Pubitemid 17070063)
29. A.C. Novick, M.C. Kaye, and D.M. Cosgrove Experience with cardiopulmonary bypass and deep hypothermic circulatory arrest in the management of retroperitoneal tumors with large vena caval thrombi Ann Surg 212 1990 472 476 discussion 476-7
30. A. Reissigl, G. Janetschek, and J. Eberle Renal cell carcinoma extending into the vena cava: surgical approach, technique and results Br J Urol 75 1995 138 142
31. D.J. Swierzewski, M.J. Swierzewski, and J.A. Libertino Radical nephrectomy in patients with renal cell carcinoma with venous, vena caval, and atrial extension Am J Surg 168 1994 205 209 (Pubitemid 24332562)
32. A. Moinzadeh, and J.A. Libertino Prognostic significance of tumor thrombus level in patients with renal cell carcinoma and venous tumor thrombus extension. Is all T3b the same? J Urol 171 2004 598 601 (Pubitemid 38090438)
33. A.J. Pantuck, A. Zisman, and F. Dorey Renal cell carcinoma with retroperitoneal lymph nodes: role of lymph node dissection J Urol 169 2003 2076 2083 (Pubitemid 36576722)
34. S.E. Canfield, A.M. Kamat, R.F. Sanchez-Ortiz, M. Detry, D.A. Swanson, and C.G. Wood Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome J Urol 175 2006 864 869 (Pubitemid 43199998)
35. P.I. Karakiewicz, Q.-D. Trinh, and N. Bhojani Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease: prognostic indicators of disease-specific survival Eur Urol 51 2007 1616 1624 (Pubitemid 46634745)
36. Delacroix S, Chapin BF, Chen JJ, et al. Can a durable disease free survival be achieved with surgical resection in patients with pathologic node positive renal cell carcinoma? J Urol. In press.
37. J.M. Whitson, C.R. Harris, A.C. Reese, and M.V. Meng Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases J Urol 185 2011 1615 1620
38. J.H. Blom, F.H. Schroder, B. Hammond, and R. Sylvester Radical nephrectomy with and without lymph node dissection: preliminary results of EORTC Protocol 30881. The EORTC Genitourinary Group Prog Clin Biol Res 378 1992 161 167
39. J.R. Vasselli, J.C. Yang, W.M. Linehan, D.E. White, S.A. Rosenberg, and M.M. Walther Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma J Urol 166 2001 68 72 (Pubitemid 32565344)
40. M.L. Blute, B.C. Leibovich, J.C. Cheville, C.M. Lohse, and H. Zincke A protocol for performing extended lymph node dissection using primary tumor pathological features for patients treated with radical nephrectomy for clear cell renal cell carcinoma J Urol 172 2004 465 469 (Pubitemid 38900178)
41. R.H. Thompson, G.V. Raj, B.C. Leibovich, P. Russo, M.L. Blute, and M.W. Kattan Preoperative nomogram to predict positive lymph nodes during nephrectomy for renal cell carcinoma J Urol 179 2008 2146 2151
42. C. Terrone, S. Guercio, and S. De Luca The number of lymph nodes examined and staging accuracy in renal cell carcinoma BJU Int 91 2003 37 40
43. S.A. Joslyn, S.J. Sirintrapun, and B.R. Konety Impact of lymphadenectomy and nodal burden in renal cell carcinoma: retrospective analysis of the National Surveillance, Epidemiology, and End Results database Urology 65 2005 675 680 (Pubitemid 40522998)
44. A.E. Parker Studies on the main posterior lymph channels of the abdomen and their connections with the lymphatics of the genito-urinary system Am J Anat 56 1935 409 413
45. P.L. Crispen, R.H. Breau, and C. Allmer Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: indications and recommendations for surgical templates Eur Urol 59 2011 18 23
46. V. Margulis, R.F. Sanchez-Ortiz, P. Tamboli, D.D. Cohen, D.A. Swanson, and C.G. Wood Renal cell carcinoma clinically involving adjacent organs: experience with aggressive surgical management Cancer 109 2007 2025 2030 (Pubitemid 46744197)
47. M.E. Karellas, T.L. Jang, M.A. Kagiwada, M.D. Kinnaman, W.R. Jarnagin, and P. Russo Advanced-stage renal cell carcinoma treated by radical nephrectomy and adjacent organ or structure resection BJU Int 103 2009 160 164
48. U. Capitanio, P. Perrotte, and L. Zini Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma) BJU Int 104 2009 795 799
49. L.M. Hock, J. Lynch, and K.C. Balaji Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data J Urol 167 2002 57 60 (Pubitemid 34024497)
50. S. Manjunath, C. Ramachandra, V. Murthy, P.S. Murthy, P.S. Prabhakaran, and V.S. Attili Surgical resection for locally invasive renal cell carcinoma: Is it worthwhile? Indian J Urol 23 2007 246 249
51. A. Bex, A.A. van der Veldt, and C. Blank Neoadjuvant sunitinib for surgically complex advanced renal cell cancer of doubtful resectability: initial experience with downsizing to reconsider cytoreductive surgery World J Urol 27 2009 533 539
52. J. La Rochelle, T. Klatte, and A. Dastane Chromosome 9p deletions identify an aggressive phenotype of clear cell renal cell carcinoma Cancer 116 2010 4696 4702
53. G. Pizzocaro, L. Piva, R. Salvioni, G. Di Fronzo, E. Ronchi, and P. Miodini Adjuvant medroxyprogesterone acetate and steroid hormone receptors in category M0 renal cell carcinoma. An interim report of a prospective randomized study J Urol 135 1986 18 21 (Pubitemid 16187140)
54. G. Pizzocaro, L. Piva, and G. Di Fronzo Adjuvant medroxyprogesterone acetate to radical nephrectomy in renal cancer: 5-year results of a prospective randomized study J Urol 138 1987 1379 1381 (Pubitemid 18006806)
55. R. Makarewicz, M. Zarzycka, G. Kulinska, and W. Windorbska The value of postoperative radiotherapy in advanced renal cell cancer Neoplasma 45 1998 380 383 (Pubitemid 29116289)
56. A. Rodriguez, and W.J. Sexton Management of locally advanced renal cell carcinoma Cancer Control 13 2006 199 210 (Pubitemid 44469741)
57. J. Atzpodien, E. Schmitt, and U. Gertenbach Adjuvant treatment with interleukin-2- and interferon-alpha2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN) Br J Cancer 92 2005 843 846 (Pubitemid 40462628)
58. P.F. Mulders, and P.H. De Mulder The role of adjuvant immunotherapy in renal cell carcinoma Curr Urol Rep 3 2002 44 49
59. S.H. Jeon, S.G. Chang, and J.I. Kim The role of adjuvant immunotherapy after radical nephrectomy and prognostic factors in pT3N0M0 renal cell carcinoma Anticancer Res 19 1999 5593 5597 (Pubitemid 30093334)
60. R. Basting, S. Corvin, D. Handel, A. Hinke, and D. Schmidt Adjuvant immunotherapy in renal cell carcinoma - comparison of interferon alpha treatment with an untreated control Anticancer Res 19 1999 1545 1548 (Pubitemid 29255644)
61. R. Migliari, G. Muscas, and A. Solinas Is there a role for adjuvant immunochemotherapy after radical nephrectomy in pT2-3N0M0 renal cell carcinoma? J Chemother 7 1995 240 245
62. R. Repmann, A.J. Goldschmidt, and A. Richter Adjuvant therapy of renal cell carcinoma patients with an autologous tumor cell lysate vaccine: a 5-year follow-up analysis Anticancer Res 23 2003 969 974 (Pubitemid 36750904)
63. C. Wood, P. Srivastava, and R. Bukowski An adjuvant autologous therapeutic vaccine (HSPPC-96; vitespen) versus observation alone for patients at high risk of recurrence after nephrectomy for renal cell carcinoma: a multicentre, open-label, randomised phase III trial Lancet 372 2008 145 154
64. H. Uemura, and M.A. De Velasco Tumor vaccines in renal cell carcinoma World J Urol 26 2008 147 154
65. H. Kubler, and J. Vieweg Vaccines in renal cell carcinoma Semin Oncol 33 2006 614 624 (Pubitemid 44511981)
66. D. Jocham, A. Richter, and L. Hoffmann Adjuvant autologous renal tumour cell vaccine and risk of tumour progression in patients with renal-cell carcinoma after radical nephrectomy: phase III, randomised controlled trial Lancet 363 2004 594 599 (Pubitemid 38264176)
67. E. Galligioni, M. Quaia, and A. Merlo Adjuvant immunotherapy treatment of renal carcinoma patients with autologous tumor cells and bacillus Calmette-Guérin: five-year results of a prospective randomized study Cancer 77 1996 2560 2566
68. V. Margulis, S.F. Matin, and N. Tannir Randomized trial of adjuvant thalidomide versus observation in patients with completely resected high-risk renal cell carcinoma Urology 73 2009 337 341
69. A. Kapoor, A. Gharajeh, A. Sheikh, and J. Pinthus Adjuvant and neoadjuvant small-molecule targeted therapy in high-risk renal cell carcinoma Curr Oncol 16 Suppl 1 2009 S60 S66
70. D.A. Kunkle, N.B. Haas, and R.G. Uzzo Adjuvant therapy for high-risk renal cell carcinoma patients Curr Urol Rep 8 2007 19 30 (Pubitemid 46202655)
71. C.G. Wood Adjuvant approaches to renal cell carcinoma Clin Adv Hematol Oncol 6 2008 19 21 (Pubitemid 351479698)
72. D. Kalman, and E. Varenhorst The role of arterial embolization in renal cell carcinoma Scand J Urol Nephrol 33 1999 162 170 (Pubitemid 29356216)
73. H. Zielinski, S. Szmigielski, and Z. Petrovich Comparison of preoperative embolization followed by radical nephrectomy with radical nephrectomy alone for renal cell carcinoma Am J Clin Oncol 23 2000 6 12 (Pubitemid 30407347)
74. W.F. Spencer, and W.M. Linehan Immunotherapy with interleukin-2 and alpha-interferon in patients with metastatic renal cell cancer with in situ primary cancers: a pilot study J Urol 147 1992 24 30
75. J.R. Wagner, M.M. Walther, W.M. Linehan, D.E. White, S.A. Rosenberg, and J.C. Yang Interleukin-2 based immunotherapy for metastatic renal cell carcinoma with the kidney in place J Urol 162 1999 43 45 (Pubitemid 29420876)
76. A.A. van der Veldt, M.R. Meijerink, and A.J. van den Eertwegh Sunitinib for treatment of advanced renal cell cancer: primary tumor response Clin Cancer Res 14 2008 2431 2436 (Pubitemid 351551077)
77. J.L. Silberstein, F. Millard, and R. Mehrazin Feasibility and efficacy of neoadjuvant sunitinib before nephron-sparing surgery BJU Int 106 2010 1270 1276
78. C.L. Cowey, C. Amin, and R.S. Pruthi Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinoma J Clin Oncol 28 2010 1502 1507
79. E. Jonasch, C.G. Wood, and S.F. Matin Phase II presurgical feasibility study of bevacizumab in untreated patients with metastatic renal cell carcinoma J Clin Oncol 27 2009 4076 4081
80. C.G. Wood, and V. Margulis Neoadjuvant (presurgical) therapy for renal cell carcinoma: a new treatment paradigm for locally advanced and metastatic disease Cancer 115 2009 2355 2360
81. V. Margulis, and C.G. Wood Cytoreductive nephrectomy in the era of targeted molecular agents: is it time to consider presurgical systemic therapy? Eur Urol 54 2008 489 492
82. V. Margulis, M. McDonald, P. Tamboli, D.A. Swanson, and C.G. Wood Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma J Urol 181 2009 2044 2051
83. D. Esrig, T.E. Ahlering, G. Lieskovsky, and D.G. Skinner Experience with fossa recurrence of renal cell carcinoma J Urol 147 1992 1491 1494
84. S. Tanguay, L.L. Pisters, D.D. Lawrence, and C.P. Dinney Therapy of locally recurrent renal cell carcinoma after nephrectomy J Urol 155 1996 26 29 (Pubitemid 126426424)
85. N.B. Itano, M.L. Blute, B. Spotts, and H. Zincke Outcome of isolated renal cell carcinoma fossa recurrence after nephrectomy J Urol 164 2000 322 325 (Pubitemid 30481915)
86. J.A. Karam, B.I. Rini, and L. Varella Metastasectomy after targeted therapy in patients with advanced renal cell carcinoma J Urol 185 2011 439 444